![](https://www.businessmarketinsights.com/assets/img/reports-icon.png)
2028년까지 중동 및 아프리카 뇌암 진단 시장 예측 – 진단 유형(영상 검사, 요추 천자, 생검, 분자 검사 및 기타)별 코로나19 영향 및 지역 분석; 암 유형(청각신경종, 성상세포종, 두개인두종, 신경절신경종, 다형성 교모세포종, 수막종, 뇌막세포종 및 기타); 최종 사용자(병원, 전문 진료소, 외래 수술 센터 등)
시장 소개
뇌암은 종양을 유발하는 뇌 세포의 세포외 성장으로 인해 발생합니다. 종양에는 원발성 뇌종양과 이차성 뇌종양이 있습니다. 원발성 뇌종양은 뇌에서 형성되며 신체의 다른 부위로 퍼지지 않는 반면, 전이라고도 알려진 이차 종양은 신체의 다른 부위에서 시작된 암입니다. 뇌종양은 40가지 주요 유형으로 분류되며, 더 나아가 성장 속도가 느리고 전이 가능성이 낮은 양성 유형과 암성이며 전이 가능성이 높은 악성 유형의 두 가지 주요 그룹으로 더 분류됩니다.
< p>따라서 뇌암 유병률의 증가는 향후 뇌암 진단에 대한 상당한 수요를 창출할 것으로 예상되며, 이는 뇌암 진단 시장을 더욱 주도할 것으로 예상됩니다.팬데믹으로 인해 전 세계적으로 의료 서비스가 중단되고 국가가 뇌암과 같은 중요한 질환을 해결하고 대응하는 능력에 영향을 미쳤습니다. 많은 국가에서 진단 서비스가 중단되고 주요 상품에 대한 공급망이 확장되었습니다. 아프리카에서는 코로나19로 인해 뇌암을 포함한 주요 건강 질환의 통제가 위협받고 있습니다. COVID-19가 아프리카에서 계속 확산됨에 따라 시장에 미치는 영향, 제한된 진단, 전문 신경외과 의사에 대한 접근성 감소에 대한 우려가 이 지역 시장에 더욱 영향을 미치고 있습니다. 그러나 팬데믹 상황이 극복되면서 뇌암 진단에 사용되는 여러 진단 방식에 대한 수요가 증가할 것입니다.
< p>시장 개요 및 역학
중동 및 아프리카의 뇌암 진단 시장은 2021년 8,740만 달러에서 미국까지 성장할 것으로 예상됩니다. 2028년까지 2억 3,700만 달러; 2021년부터 2028년까지 연평균 성장률(CAGR) 15.3%로 증가할 것으로 추정됩니다. \'원발성 뇌종양\'이라는 용어는 뇌에서 시작되는 종양을 말합니다. 뇌암과 신경계암은 남성과 여성의 사망 원인 중 10번째로 높은 암입니다. 사람의 일생 동안 이런 형태의 종양이 생길 확률은 1% 미만입니다. 대부분의 원발성 중추신경계(CNS) 악성 종양은 뇌종양으로 전체 사례의 85~90%를 차지합니다. 뇌종양은 치명적일 수 있고 삶의 질에 심각한 영향을 미치며 궁극적으로 환자와 그 가족의 삶을 변화시킬 수 있습니다. 게다가, 종양의 조기 발견은 종종 더 많은 치료 옵션을 제공합니다. 첨단 영상 기술로 뇌종양의 위치를 정확히 찾아낼 수 있습니다. 진단 도구에는 자기공명영상(MRI)과 컴퓨터 단층촬영(CT 또는 CAT 스캔)이 포함됩니다. 수술 중 MRI는 수술 중 조직 생검 및 종양 절제를 안내하는 데에도 사용할 수 있습니다. 자기공명분광법(MRS)은 종양의 화학적 특성을 검사하는 데 사용됩니다. 따라서 뇌암의 유병률이 증가함에 따라 뇌암 진단 도구에 대한 수요가 높아지고 있습니다.
주요 시장 부문
측면에서 진단 유형별로는 영상 테스트 부문이 2020년 중동 및 아프리카 뇌암 진단 시장에서 가장 큰 점유율을 차지했습니다. 암 유형별로는 다형성 교모세포종 부문이 중동 및 아프리카 뇌암 진단에서 가장 큰 점유율을 차지했습니다. 최종 사용자 측면에서 보면 병원 부문이 2020년 중동 및 아프리카 뇌암 진단 시장에서 가장 큰 점유율을 차지했습니다.
주요 출처 및 나열된 회사
이 보고서를 준비하는 데 참조된 몇 가지 주요 1차 및 2차 출처 중동 및 아프리카의 뇌암 진단 시장에는 회사 웹사이트, 연례 보고서, 재무 보고서, 국가 정부 문서, 통계 데이터베이스 등이 있습니다. 보고서에 나열된 주요 회사로는 Thermo Fisher Scientific Inc., Siemens Healthineers A, GE Healthcare, Biocept, Inc., Koninklijke Philips NV, Canon Medical Systems, Hitachi, Ltd. 및 Neusoft Medical Systems가 있습니다.
이유 보고서 구매
- 중동 및 아프리카 뇌암 진단 시장 환경을 이해하고 가장 가능성이 높은 시장 부문을 식별합니다. 강력한 수익 보장
- 중동 및 아프리카 뇌암 진단 시장의 끊임없이 변화하는 경쟁 환경을 이해하여 경쟁에서 앞서 나가십시오.
- 중동 지역에서 M&A 및 파트너십 거래를 효율적으로 계획하세요 가장 유망한 예상 판매가 있는 시장 부문을 식별하여 동부 및 아프리카 뇌암 진단 시장
- 중동 및 아프리카 뇌암 진단 시장의 다양한 부문의 시장 성과에 대한 통찰력 있고 포괄적인 분석을 통해 지식이 풍부한 비즈니스 결정을 내리는 데 도움이 됩니다.
- 2021~2028년 중동 및 아프리카 지역의 다양한 부문별 시장 수익 예측을 얻습니다.
중동 및 아프리카 뇌암 진단 시장 세분화
진단 유형별
- 영상 테스트
- MRI
- CT 스캔
- PET
- 생검
- 분자 검사
- 요추 천자
- 기타
암 유형별
- 다형성 교모세포종
- 성상세포종
- 상세포종
- 기타
작성자최종 사용자
- 병원
- 전문 진료소
- 외래 수술 센터
- 기타
국가별
- 중동 및 아프리카
- UAE
- 사우디아라비아
- 남아프리카공화국
- 중동 및 아프리카 나머지 지역
언급된 회사
- Thermo Fisher Scientific Inc.
- Siemens Healthineers A
- GE 헬스케어
- Biocept, Inc.
- Koninklijke Philips NV
- Canon Medical Systems
- Hitachi, Ltd.
- Neusoft Medical Systems
TABLE OF CONTENTS
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Brain Cancer Diagnostics Market – By Diagnostic Type
1.3.2 Brain Cancer Diagnostics Market – By Cancer Type
1.3.3 Brain Cancer Diagnostics Market – By End User
1.3.4 Middle East and Africa Brain Cancer Diagnostics Market – By Country
2. Middle East and Africa Brain Cancer Diagnostics Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Middle East and Africa Brain Cancer Diagnostics Market – Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 Brain Cancer Diagnostics Market- Middle East and Africa PEST Analysis
4.3 Expert Opinion
5. Middle East and Africa Brain Cancer Diagnostics Market - Key Market Dynamics
5.1 Market Drivers
5.1.1 Increase in Prevalence of Brain Cancer
5.1.2 Rise in Number of Cigarette Smokers
5.2 Market Restraints
5.2.1 High Cost of Diagnosis
5.3 Future Trends
5.3.1 Use of Stimulated Raman Histology (SRH)?Artificial Intelligence (AI) to Enhance Brain Tumor Diagnosis During Surgery
5.4 Impact Analysis
6. Brain Cancer Diagnostics Market – Middle East and Africa Analysis
6.1 Middle East and Africa Brain Cancer Diagnostics Market Revenue Forecasts and Analysis
7. Middle East and Africa Brain Cancer Diagnostics Market Analysis and Forecasts To 2028 – By Diagnostic Type
7.1 Overview
7.2 Brain Cancer Diagnostics Market Revenue Share, by Diagnostic Type (2020 and 2028)
7.3 Imaging Tests
7.3.1 Overview
7.3.2 Imaging Tests: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
7.3.3 MRI
7.3.3.1 Overview
7.3.3.2 MRI: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
7.3.4 CT Scan
7.3.4.1 Overview
7.3.4.2 CT Scan: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
7.3.5 Positron emission tomography (PET)
7.3.5.1 Overview
7.3.5.2 Positron emission tomography (PET): Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
7.4 Lumbar Puncture
7.4.1 Overview
7.4.2 Lumbar Puncture: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
7.5 Biopsy
7.5.1 Overview
7.5.2 Biopsy: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
7.6 Molecular Testing
7.6.1 Overview
7.6.2 Molecular Testing: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
7.7 Others
7.7.1 Overview
7.7.2 Others: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
8. Middle East and Africa Brain Cancer Diagnostics Market Analysis and Forecasts To 2028 – By Cancer Type
8.1 Overview
8.2 Brain Cancer Diagnostics Market Revenue Share, by Cancer Type (2020 and 2028)
8.3 Astrocytomas
8.3.1 Overview
8.3.2 Astrocytomas: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
8.4 Glioblastoma Multiforme
8.4.1 Overview
8.4.2 Glioblastoma Multiforme: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
8.5 Ependymomas
8.5.1 Overview
8.5.2 Ependymomas: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
8.6 Others
8.6.1 Overview
8.6.2 Others: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
9. Brain Cancer Diagnostics Market Analysis – By End user
9.1 Overview
9.2 Brain Cancer Diagnostics Market Revenue Share, by End User (2020 and 2028)
9.3 Hospitals
9.3.1 Overview
9.3.2 Hospitals: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
9.4 Specialty Clinics
9.4.1 Overview
9.4.2 Specialty Clinics: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
9.5 Ambulatory Surgical Centers
9.5.1 Overview
9.5.2 Ambulatory Surgical Centers: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
9.6 Others
9.6.1 Overview
9.6.2 Others: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
10. Brain Cancer Diagnostics Market Revenue and Forecasts to 2028 – Geographical Analysis
10.1 Middle East and Africa: Brain Cancer Diagnostics Market
10.1.1 Overview
10.1.2 Middle East and Africa: Brain Cancer Diagnostics Market, by Country, 2021 & 2028 (%)
10.1.2.1 Saudi Arabia: Brain Cancer Diagnostics Market– Revenue and Forecast to 2028 (US$ Million)
10.1.2.1.1 Saudi Arabia: Brain Cancer Diagnostics Market– Revenue and Forecast to 2028 (US$ Million)
10.1.2.1.2 Saudi Arabia Brain Cancer Diagnostics Market, by Diagnostics Type– Revenue and Forecast to 2028 (USD Million)
10.1.2.1.2.1 Saudi Arabia Brain Cancer Diagnostics Market, by Imaging Test– Revenue and Forecast to 2028 (USD Million)
10.1.2.1.3 Saudi Arabia Brain Cancer Diagnostics Market, by Cancer Type– Revenue and Forecast to 2028 (USD Million)
10.1.2.1.4 Saudi Arabia Brain Cancer Diagnostics Market, by End User– Revenue and Forecast to 2028 (USD Million)
10.1.2.2 UAE: Brain Cancer Diagnostics Market– Revenue and Forecast to 2028 (US$ Million)
10.1.2.2.1 UAE: Brain Cancer Diagnostics Market– Revenue and Forecast to 2028 (US$ Million)
10.1.2.2.2 UAE Brain Cancer Diagnostics Market, by Diagnostics Type– Revenue and Forecast to 2028 (USD Million)
10.1.2.2.2.1 UAE Brain Cancer Diagnostics Market, by Imaging Test– Revenue and Forecast to 2028 (USD Million)
10.1.2.2.3 UAE Brain Cancer Diagnostics Market, by Cancer Type– Revenue and Forecast to 2028 (USD Million)
10.1.2.2.4 UAE Brain Cancer Diagnostics Market, by End User– Revenue and Forecast to 2028 (USD Million)
10.1.2.3 South Africa: Brain Cancer Diagnostics Market– Revenue and Forecast to 2028 (US$ Million)
10.1.2.3.1 South Africa: Brain Cancer Diagnostics Market– Revenue and Forecast to 2028 (US$ Million)
10.1.2.3.2 South Africa Brain Cancer Diagnostics Market, by Diagnostics Type– Revenue and Forecast to 2028 (USD Million)
10.1.2.3.2.1 South Africa Brain Cancer Diagnostics Market, by Imaging Test– Revenue and Forecast to 2028 (USD Million)
10.1.2.3.3 South Africa Brain Cancer Diagnostics Market, by Cancer Type– Revenue and Forecast to 2028 (USD Million)
10.1.2.3.4 South Africa Brain Cancer Diagnostics Market, by End User– Revenue and Forecast to 2028 (USD Million)
10.1.2.4 Rest of Middle East and Africa: Brain Cancer Diagnostics Market– Revenue and Forecast to 2028 (US$ Million)
10.1.2.4.1 Rest of Middle East and Africa: Brain Cancer Diagnostics Market– Revenue and Forecast to 2028 (US$ Million)
10.1.2.4.2 Rest of Middle East and Africa Brain Cancer Diagnostics Market, by Diagnostics Type– Revenue and Forecast to 2028 (USD Million)
10.1.2.4.2.1 Rest of Middle East and Africa Brain Cancer Diagnostics Market, by Imaging Test – Revenue and Forecast to 2028 (USD Million)
10.1.2.4.3 Rest of Middle East and Africa Brain Cancer Diagnostics Market, by Cancer Type– Revenue and Forecast to 2028 (USD Million)
10.1.2.4.4 Rest of Middle East and Africa Brain Cancer Diagnostics Market, by End User– Revenue and Forecast to 2028 (USD Million)
11. Impact Of COVID-19 Pandemic on Middle East and Africa Brain Cancer Diagnostics Market
11.1 Middle East and Africa: Impact Assessment of COVID-19 Pandemic
12. Industry Landscape
12.1 Overview
12.2 Growth Strategies Done by the Companies in the Market, (%)
12.1 Organic Developments
12.1.1 Overview
12.2 Inorganic Developments
12.2.1 Overview
13. Company Profiles
13.1 THERMO FISHER SCIENTIFIC INC.
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 Siemens Healthineers AG
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 GE Healthcare
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 Biocept, Inc.
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 Koninklijke Philips N.V.
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 Canon Medical Systems
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 Hitachi, Ltd.
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 Neusoft Medical Systems
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
14. Appendix
14.1 About the Insight Partners
14.2 Glossary of Terms
LIST OF TABLES
Table 1. Saudi Arabia Brain Cancer Diagnostics Market, by Diagnostics Type – Revenue and Forecast to 2028 (USD Million)
Table 2. Saudi Arabia Brain Cancer Diagnostics Market, by Imaging Test – Revenue and Forecast to 2028 (USD Million)
Table 3. Saudi Arabia Brain Cancer Diagnostics Market, by Cancer Type – Revenue and Forecast to 2028 (USD Million)
Table 4. Saudi Arabia Brain Cancer Diagnostics Market, by End User– Revenue and Forecast to 2028 (USD Million)
Table 5. UAE Brain Cancer Diagnostics Market, by Diagnostics Type – Revenue and Forecast to 2028 (USD Million)
Table 6. UAE Brain Cancer Diagnostics Market, by Imaging Test – Revenue and Forecast to 2028 (USD Million)
Table 7. UAE Brain Cancer Diagnostics Market, by Cancer Type – Revenue and Forecast to 2028 (USD Million)
Table 8. UAE Brain Cancer Diagnostics Market, by End User– Revenue and Forecast to 2028 (USD Million)
Table 9. South Africa Brain Cancer Diagnostics Market, by Diagnostics Type – Revenue and Forecast to 2028 (USD Million)
Table 10. South Africa Brain Cancer Diagnostics Market, by Imaging Test – Revenue and Forecast to 2028 (USD Million)
Table 11. South Africa Brain Cancer Diagnostics Market, by Cancer Type – Revenue and Forecast to 2028 (USD Million)
Table 12. South Africa Brain Cancer Diagnostics Market, by End User– Revenue and Forecast to 2028 (USD Million)
Table 13. Rest of Middle East and Africa Brain Cancer Diagnostics Market, by Diagnostics Type – Revenue and Forecast to 2028 (USD Million)
Table 14. Rest of Middle East and Africa Brain Cancer Diagnostics Market, by Imaging Test – Revenue and Forecast to 2028 (USD Million)
Table 15. Rest of Middle East and Africa Brain Cancer Diagnostics Market, by Cancer Type – Revenue and Forecast to 2028 (USD Million)
Table 16. Rest of Middle East and Africa Brain Cancer Diagnostics Market, by End User– Revenue and Forecast to 2028 (USD Million)
Table 17. Organic Developments in the Brain Cancer Diagnostics Market
Table 18. Inorganic Developments in the Brain Cancer Diagnostics Market
Table 19. Glossary of Terms, Brain Cancer Diagnostics Market
LIST OF FIGURES
Figure 1. Brain Cancer Diagnostics Market Segmentation
Figure 2. Middle East and Africa Brain Cancer Diagnostics Market Overview
Figure 3. Imaging Test Segment Held Largest Share of Diagnostic Type in Brain Cancer Diagnostics Market
Figure 4. Saudi Arabia is Expected to Show Remarkable Growth During the Forecast Period
Figure 5. Brain Cancer Diagnostics Market - Middle East and Africa PEST Analysis
Figure 6. Brain Cancer Diagnostics Market Impact Analysis of Driver and Restraints
Figure 7. Middle East and Africa Brain cancer diagnostics Market – Revenue Forecasts and Analysis – 2020- 2028
Figure 8. Brain Cancer Diagnostics Market Revenue Share, by Diagnostic Type (2020 and 2028)
Figure 9. Imaging Tests: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 10. MRI: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 11. CT Scan: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 12. Positron emission tomography (PET): Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 13. Lumbar Puncture: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 14. Biopsy: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 15. Molecular Testing: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 16. Others: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 17. Brain Cancer Diagnostics Market Revenue Share, by Cancer Type (2020 and 2028)
Figure 18. Astrocytomas: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 19. Glioblastoma Multiforme: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 20. Ependymomas: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 21. Others: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 22. Brain Cancer Diagnostics Market Revenue Share, by End User (2020 and 2028)
Figure 23. Hospitals: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 24. Specialty Clinics: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 25. Ambulatory Surgical Centers: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 26. Others: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 27. Middle East and Africa: Brain Cancer Diagnostics Market, by Key Country – Revenue (2021) (USD Million)
Figure 28. Middle East and Africa: Brain Cancer Diagnostics Market, by Country, 2021 & 2028 (%)
Figure 29. Saudi Arabia: Brain Cancer Diagnostics Market– Revenue and Forecast to 2028 (US$ Million)
Figure 30. UAE: Brain Cancer Diagnostics Market– Revenue and Forecast to 2028 (US$ Million)
Figure 31. South Africa: Brain Cancer Diagnostics Market– Revenue and Forecast to 2028 (US$ Million)
Figure 32. Rest of Middle East and Africa: Brain Cancer Diagnostics Market– Revenue and Forecast to 2028 (US$ Million)
Figure 33. Impact of COVID-19 Pandemic in Middle East and African Country Markets
Figure 34. Growth Strategies Done by the Companies in the Market, (%)
- Thermo Fisher Scientific Inc.
- Siemens Healthineers A
- GE Healthcare
- Biocept, Inc.
- Koninklijke Philips N.V
- Canon Medical Systems
- Hitachi, Ltd.
- Neusoft Medical Systems
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the Middle East and Africa brain cancer diagnostics market.
- Highlights key business priorities in order to assist companies to realign their business strategies
- The key findings and recommendations highlight crucial progressive industry trends in the Middle East and Africa brain cancer diagnostics market, thereby allowing players across the value chain to develop effective long-term strategies
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
- Scrutinize in-depth Middle East and Africa market trends and outlook coupled with the factors driving the brain cancer diagnostics market, as well as those hindering it
- Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing and distribution